Skip to main content

Abcellera Biologics Inc(ABCL-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Volume

Latest News

Why AbCellera Biologics Is 10% Lower Today
Motley Fool - Wed May 11, 11:54AM CDT
Motley Fool
Wed May 11, 11:54AM CDT
The company has a plan for life after COVID-19, though it pales in comparison.
AbCellera Biologics Inc. (ABCL) Q1 2022 Earnings Call Transcript
Motley Fool - Wed May 11, 1:00AM CDT
Motley Fool
Wed May 11, 1:00AM CDT
ABCL earnings call for the period ending March 31, 2022.
AbCellera Reports Q1 2022 Business Results
Business Wire - Tue May 10, 3:05PM CDT
Business Wire
Tue May 10, 3:05PM CDT
AbCellera (Nasdaq: ABCL), a technology company with a centralized operating system for next-generation antibody discovery, today announced financial results for the first quarter of 2022. All financial information in this press release is...
AbCellera and Empirico Expand Strategic Multi-Target Antibody Discovery Collaboration
Business Wire - Tue May 3, 8:00AM CDT
Business Wire
Tue May 3, 8:00AM CDT
AbCellera (Nasdaq: ABCL) and Empirico Inc. (“Empirico”) announced today that they have expanded their strategic multi-target discovery collaboration, which leverages Empirico’s Precision Insights Platform TM to discover genetically validated...
AbCellera to Present at the 2022 Bloom Burton & Co. Healthcare Investor Conference on May 2, 2022
Business Wire - Tue Apr 26, 3:05PM CDT
Business Wire
Tue Apr 26, 3:05PM CDT
AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the 2022 Bloom Burton & Co. Healthcare Investor Conference on Monday, May 2, 2022, in Toronto, Canada at 6:30 a.m. Pacific Time (9:30 a.m. Eastern Time).
AbCellera to Report First Quarter 2022 Financial Results on May 10, 2022
Business Wire - Tue Apr 12, 3:05PM CDT
Business Wire
Tue Apr 12, 3:05PM CDT
AbCellera (Nasdaq: ABCL) will announce its first quarter 2022 financial results on Tuesday, May 10, 2022, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.
AbCellera Presents Data on T Cell Engager Platform at AACR 2022
Business Wire - Fri Apr 8, 12:05PM CDT
Business Wire
Fri Apr 8, 12:05PM CDT
AbCellera (Nasdaq: ABCL), a technology company focused on next-generation antibody discovery, today announced the release of data on its new T cell engager platform at the American Association for Cancer Research (AACR) 2022 Annual Meeting....
AbCellera Biologics Inc. (ABCL) Q4 2021 Earnings Call Transcript
Motley Fool - Fri Feb 25, 6:00AM CST
Motley Fool
Fri Feb 25, 6:00AM CST
ABCL earnings call for the period ending December 31, 2021.
AbCellera Reports Full Year 2021 Business Results
Business Wire - Thu Feb 24, 3:05PM CST
Business Wire
Thu Feb 24, 3:05PM CST
AbCellera (Nasdaq: ABCL), a technology company with a centralized operating system for next-generation antibody discovery, today announced financial results for full year 2021. All financial information in this press release is reported in U.S....
AbCellera to Participate Virtually in the Truist Securities AI Symposium – Biotech & Tools
Business Wire - Wed Feb 23, 3:05PM CST
Business Wire
Wed Feb 23, 3:05PM CST
AbCellera (Nasdaq: ABCL) today announced that executives from the Company will participate in a panel during the Truist Securities AI Symposium – Biotech & Tools. The panel is titled, “Integrated Platforms for AI-based Drug Discovery,” and...